Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 18 Nov 2022

Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice

in Respiratory Pharmacology

Yanrong Long
Hongbin Chen
Junchao Deng
Junjie Ning
Pengbo Yang
Lina Qiao
Zhongwei Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1039103

3,853 views
5 citations

Original Research

Published on 16 Nov 2022

Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism

in Respiratory Pharmacology

Chunlan Tang
Yuqing Tang
Qinwen Wang
Donghui Chu
Jinyue Zhou
Yuping Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1056078

2,508 views
9 citations

Review

Published on 16 Nov 2022

The protective effect of natural medicines against excessive inflammation and oxidative stress in acute lung injury by regulating the Nrf2 signaling pathway

in Respiratory Pharmacology

Rumei Luan
Dongyan Ding
Junling Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1039022

3,876 views
25 citations

Review

Published on 15 Nov 2022

Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment

in Respiratory Pharmacology

Tingwei Zhang
Jinjin Zhang
Changjun Lv
Hongbo Li
Xiaodong Song

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1059434

6,402 views
15 citations

Original Research

Published on 11 Nov 2022

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation

in Respiratory Pharmacology

Shiu-Wan Chan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1007527

5,505 views
8 citations

Original Research

Published on 07 Nov 2022

Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in mice

in Respiratory Pharmacology

Pavel A. Solopov
Ruben Manuel Luciano Colunga Biancatelli
Christiana Dimitropolou
Tierney Day
John D. Catravas

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1034464

2,259 views
8 citations

Editorial

Published on 07 Nov 2022

Editorial: Insights in respiratory pharmacology: 2021

in Respiratory Pharmacology

Paolo Montuschi
Irfan Rahman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1052994

1,808 views

Review

Published on 03 Nov 2022

Highway to heal: Influence of altered extracellular matrix on infiltrating immune cells during acute and chronic lung diseases

in Respiratory Pharmacology

Mugdha M. Joglekar
Mehmet Nizamoglu
YiWen Fan
Sai Sneha Priya Nemani
Markus Weckmann
Simon D. Pouwels
Irene H. Heijink
Barbro N. Melgert
Janesh Pillay
Janette K. Burgess

Frontiers in Pharmacology

doi 10.3389/fphar.2022.995051

4,736 views
12 citations

Editorial

Published on 03 Nov 2022

Editorial: Oxidative stress related to cellular metabolism in lung health and diseases

in Respiratory Pharmacology

Karuppusamy Arunachalam
Krishnan Anand
Subramanian Palanisamy
Vikas Anathy

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1015423

1,968 views
4 citations

Original Research

Published on 03 Nov 2022

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis

in Respiratory Pharmacology

Rong-Hong Guo
Hao Cheng
Xiao-Ying Zhang
Zhen Yu
Guang-Hui Wang
Shu-Ya Hao
Xiao-Peng Gao
Hong-Yan Wen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.986199

2,479 views
9 citations

Original Research

Published on 03 Nov 2022

Substrate stiffness engineered to replicate disease conditions influence senescence and fibrotic responses in primary lung fibroblasts

in Respiratory Pharmacology

Kaj E. C. Blokland
Mehmet Nizamoglu
Habibie Habibie
Theo Borghuis
Michael Schuliga
Barbro N. Melgert
Darryl A. Knight
Corry-Anke Brandsma
Simon D. Pouwels
Janette K. Burgess

Frontiers in Pharmacology

doi 10.3389/fphar.2022.989169

7,266 views
27 citations

Original Research

Published on 31 Oct 2022

Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex

in Respiratory Pharmacology

Qi Zhu
Jing Wang
Yunxia Ji
Jianlin Luan
Dayong Yue
Weili Liu
Hongbo Li
Jinjin Zhang
Guiwu Qu
Changjun Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1013098

3,196 views
3 citations

Original Research

Published on 28 Oct 2022

Differentiation and on axon-guidance chip culture of human pluripotent stem cell-derived peripheral cholinergic neurons for airway neurobiology studies

in Respiratory Pharmacology

P. A. Goldsteen
A. M. Sabogal Guaqueta
P. P. M. F. A. Mulder
I. S. T. Bos
M. Eggens
L. Van der Koog
J. T. Soeiro
A. J. Halayko
K. Mathwig
L. E. M. Kistemaker

Frontiers in Pharmacology

doi 10.3389/fphar.2022.991072

6,430 views
12 citations

Original Research

Published on 28 Oct 2022

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial

in Respiratory Pharmacology

Jiansheng Li
Xue-qing Yu
Yang Xie
Shu-guang Yang
Limin Zhao
Miao Zhou
Yong Meng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053356

4,025 views
5 citations

Review

Published on 28 Oct 2022

Pharmacologic therapies of ARDS: From natural herb to nanomedicine

in Respiratory Pharmacology

Linlin Meng
Ximing Liao
Yuanyuan Wang
Liangzhi Chen
Wei Gao
Muyun Wang
Huiling Dai
Na Yan
Yixuan Gao
Xu Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.930593

7,300 views
15 citations

Clinical Trial

Published on 21 Oct 2022

The safety and efficacy of alfentanil combined with midazolam in fiberoptic bronchoscopy sedation: A randomized, double-blind, controlled trial

in Respiratory Pharmacology

Longfei Wang
Qiuyue Wu
Ming Wang
Wanquan Ming
Cheng Sheng
Yonghua Zhang
Yongbin Chen
Yunfei Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1036840

2,574 views
9 citations